Bleda C, Soler R, Romaguera A, Mas S, Juan J M
Servicio de ORL, Hospital Son Dureta, Palma de Mallorca, Baleares.
Acta Otorrinolaringol Esp. 1998 Jun-Jul;49(5):369-72.
The value of immunotherapy (IT) in allergic rhinitis is debated. The results of a retrospective study of 67 patients treated with IT from 1985 to the end of 1995 are reported. Patients were classified as cured, improved, or not improved. Variables such as age, number and type of allergens, improvement, release, duration of evolution, and initial and final IgE levels were analyzed. Response to IT was favorable in 81.1% of cases. Improvement and cure were age-dependent, with the cure rate being significantly higher in patients over 30.
免疫疗法（IT）在过敏性鼻炎中的价值存在争议。本文报告了一项对1985年至1995年底接受IT治疗的67例患者的回顾性研究结果。患者被分为治愈、改善或未改善三类。分析了年龄、过敏原数量和类型、改善情况、缓解情况、病程持续时间以及初始和最终IgE水平等变量。81.1%的病例对IT反应良好。改善和治愈情况与年龄有关，30岁以上患者的治愈率显著更高。
